Showing results (1051-1060 of 6,286) with videos related to
Sort By:
Pageof 629
Science (New York, N.Y.)|March 9, 1979
Radiation from tritiated thymidine perturbs the cell cycle progression of stimulated lymphocytesA Pollack, C B Bagwell, G L IrvinRestorative Neurology and Neuroscience|May 10, 2011
MHC antigen expression and cellular response in spontaneous and induced rejection of intracerebral neural xenografts in neonatal ratsI F Pollack, R D Lund, K RaoDiabetes Research and Clinical Practice|January 22, 2011
Effects of hypoglycemia on health-related quality of life, treatment satisfaction and healthcare resource utilization in patients with type 2 diabetes mellitusSetareh A Williams, Michael F Pollack, Marco DibonaventuraWorld Journal of Gastrointestinal Pharmacology and Therapeutics|May 18, 2011
Mesalamine induced symptom exacerbation of ulcerative colitis: Case report and brief discussionManeesh Kumar Gupta, Scott Pollack, John J HutchingsCurrent Medical Research and Opinion|June 15, 2007
Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United StatesM Jhaveri, B Seal, M Pollack, et al.Behavioral Medicine (Washington, D.C.)|August 23, 2007
Psychological distress, life stressors, and social support in new immigrants with HIVMiri Cohen, Sandra Arad, Margalit Lorber, et al.The American Journal of Gastroenterology|March 1, 1979
Lymphosarcoma of the duodenum associated with carcinoma of the lung. Five-year survivalB A Payson, L A Weingarten, J PollackRetina (Philadelphia, Pa.)|January 28, 2012
Comparison of topical anesthetics for intravitreal injections : a randomized clinical trialMichael J Davis, John S Pollack, Susan ShottInternational Journal of Radiation Oncology, Biology, Physics|February 25, 1999
Familial prostate cancer: outcome following radiation therapy with or without adjuvant androgen ablationM C Hanus, G K Zagars, A PollackInternational Journal of Radiation Oncology, Biology, Physics|July 1, 1999
Conventional external-beam radiation therapy alone or with androgen ablation for clinical stage III (T3, NX/N0, M0) adenocarcinoma of the prostateG K Zagars, A Pollack, L G SmithPageof 629